Peter Kushner, Ph.D., is the former Chief Scientific Officer and co-founder of Olema Pharmaceuticals, Inc. He holds a Ph.D. in Biological Sciences and has extensive experience in the field of science. His career has spanned over several decades, including long-standing...

Peter Kushner, Ph.D., is the former Chief Scientific Officer and co-founder of Olema Pharmaceuticals, Inc. He holds a Ph.D. in Biological Sciences and has extensive experience in the field of science. His career has spanned over several decades, including long-standing roles at important institutions like UCSF, where he is Professor Emeritus. He played a key role in the development of the company’s pipeline projects, particularly focusing on clinical development goals that align with shareholder interests. In March 2022, he transitioned from his executive role to become a Senior Research Fellow, allowing him to focus more on research than on day-to-day operations. Kushner's insider trading reported substantial fluctuations in wealth linked to Olema Pharmaceuticals, peaking at over $66 million in 2020. In terms of compensation, in 2022, his total pay included a base salary of around $615,800 along with performance-based bonuses resulting in a total compensation package of almost $5.99 million. This highlights his commitment and alignment with the company's vision and achievements.